Cargando…
Low-Dose Naltrexone for Pruritus in Systemic Sclerosis
Pruritus is a common symptom in systemic sclerosis (SSc), an autoimmune disease which causes fibrosis and vasculopathy in skin, lung, and gastrointestinal tract (GIT). Unfortunately, pruritus has limited treatment options in this disease. Pilot trials of low-dose naltrexone hydrochloride (LDN) for p...
Autores principales: | Frech, Tracy, Novak, Kirsten, Revelo, Monica P., Murtaugh, Maureen, Markewitz, Boaz, Hatton, Nathan, Scholand, Mary Beth, Frech, Edward, Markewitz, David, Sawitzke, Allen D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171757/ https://www.ncbi.nlm.nih.gov/pubmed/21918649 http://dx.doi.org/10.1155/2011/804296 |
Ejemplares similares
-
The Vascular Microenvironment and Systemic Sclerosis
por: Frech, Tracy, et al.
Publicado: (2010) -
The frequency of Raynaud’s phenomenon, very early diagnosis of systemic sclerosis, and systemic sclerosis in a large Veteran Health Administration database
por: Frech, Tracy M., et al.
Publicado: (2021) -
The Prevalence and Clinical Correlates of an Auscultatory Gap in Systemic Sclerosis Patients
por: Frech, Tracy M., et al.
Publicado: (2012) -
Low-dose naltrexone as treatment for epidermolysis bullosa pruriginosa–associated refractory pruritus
por: LaMonica, Lauren C., et al.
Publicado: (2023) -
Clinical Efficacy and Safety of Naltrexone Combination Therapy in Older Patients with Severe Pruritus
por: Lee, Jungsoo, et al.
Publicado: (2016)